Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of SLCO1B3 protein | affects expression | 20106945
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of SLCO1B3 mRNA | affects expression | 16483693
|
D001647 |
Bile Acids and Salts |
SLCO1B3 protein affects the transport of Bile Acids and Salts | affects transport | 15841457
|
D001647 |
Bile Acids and Salts |
SLCO1B3 protein affects the uptake of Bile Acids and Salts | affects uptake | 15841457
|
D002220 |
Carbamazepine |
Carbamazepine results in increased expression of SLCO1B3 mRNA | increases expression | 17112801
|
D012844 |
Sincalide |
SLCO1B3 protein affects the import of Sincalide | affects import | 16046661
|
D012844 |
Sincalide |
SLCO1B3 protein affects the uptake of Sincalide | affects uptake | 15665139
|
D016572 |
Cyclosporine |
Cyclosporine inhibits the reaction [SLCO1B3 protein results in increased uptake of fexofenadine] | decreases reaction|increases uptake | 18180276
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of SLCO1B3 mRNA | increases expression | 16002434
|
C025483 |
estradiol-17 beta-glucuronide |
[SLCO1B3 protein co-treated with ABCC2 protein] results in increased uptake of estradiol-17 beta-glucuronide | affects cotreatment|increases uptake | 18180276
|
C093230 |
fexofenadine |
Cyclosporine inhibits the reaction [SLCO1B3 protein results in increased uptake of fexofenadine] | decreases reaction|increases uptake | 18180276
|
C093230 |
fexofenadine |
Rifampin inhibits the reaction [SLCO1B3 protein results in increased uptake of fexofenadine] | decreases reaction|increases uptake | 18180276
|
C093230 |
fexofenadine |
[SLCO1B3 protein co-treated with ABCC2 protein] results in increased uptake of fexofenadine | affects cotreatment|increases uptake | 18180276
|
C093230 |
fexofenadine |
SLCO1B3 protein results in increased uptake of fexofenadine | increases uptake | 18245269
|
C065180 |
fluvastatin |
SLCO1B3 protein affects the import of fluvastatin | affects import | 16046661
|
C026209 |
oltipraz |
oltipraz results in decreased expression of SLCO1B3 mRNA | decreases expression | 16837569
|
D010634 |
Phenobarbital |
Phenobarbital results in decreased expression of SLCO1B3 mRNA | decreases expression | 16837569
|
D012293 |
Rifampin |
Rifampin inhibits the reaction [SLCO1B3 protein results in increased uptake of fexofenadine] | decreases reaction|increases uptake | 18180276
|
D013448 |
Sulfobromophthalein |
SLCO1B3 protein affects the import of Sulfobromophthalein | affects import | 16046661
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of SLCO1B3 mRNA | decreases expression | 16837569
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Carbamazepine |
14.65 | 8986270 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
14.65 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
14.65 | 15322242 11752688 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.61 | 18287403 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
10.25 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.25 | 16835633 |
OMIM:607154 |
ALLERGIC RHINITIS |
|
fexofenadine |
5.79 | 16037679 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.97 | 11748828 |
MESH:D000855 |
Anorexia |
|
Sincalide |
6.68 | 15879057 |
MESH:D001714 |
Bipolar Disorder |
|
Carbamazepine |
4.15 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.07 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.85 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.78 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
2.11 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.11 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.82 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
3.10 | 12619106 21507988 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
3.10 | 17173139 6705139 1701930 20935162 20007298 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
2.63 | 11237771 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.38 | 18850075 18670907 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.54 | 12371664 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.29 | 4080065 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.19 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.83 | 19486331 |
MESH:D002779 |
Cholestasis |
|
estradiol-17 beta-glucuronide |
8.83 | 12893835 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.11 | 15340226 12621046 16354765 15668235 8697196 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.08 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
fluvastatin |
4.83 | 16142594 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Carbamazepine |
2.87 | 9014606 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.87 | 20055451 10048152 15322242 |
MESH:D003876 |
Dermatitis, Atopic |
|
fexofenadine |
4.78 | 17133778 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.67 | 17107852 |
OMIM:607208 |
DRAVET SYNDROME |
|
Carbamazepine |
5.49 | 11748493 |
MESH:D004342 |
Drug Hypersensitivity |
|
Carbamazepine |
4.42 | 16538176 15057820 20216337 16538175 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbamazepine |
4.19 | 17465707 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
4.19 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Carbamazepine |
8.47 | 20216337 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.47 | 11462148 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
4.04 | 1851702 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.41 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.96 | 15322242 16714409 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
9.78 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Carbamazepine |
9.78 | 17654737 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.05 | 10568697 9294722 |
MESH:D004816 |
Epidermal Necrolysis, Toxic |
|
Carbamazepine |
5.29 | 19915237 16538176 20485159 16415921 18855540 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Carbamazepine |
11.32 | 17275665 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
11.32 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Carbamazepine |
10.57 | 17116037 15008574 16628512 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
10.57 | 3922381 11558140 |
MESH:D004827 |
Epilepsy |
|
Carbamazepine |
7.10 | 821787 19439326 17465707 20417680 9014606 7988514 17178248 19700373 18234410 19620853 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
7.10 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.57 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Carbamazepine |
11.83 | 7750514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
11.83 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Carbamazepine |
11.04 | 3659116 15276670 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
11.04 | 3659116 |
MESH:D004916 |
Erythromelalgia |
|
Carbamazepine |
5.77 | 19549232 |
MESH:D004942 |
Esophagitis, Peptic |
|
Bile Acids and Salts |
6.62 | 11346197 |
MESH:D005076 |
Exanthema |
|
Carbamazepine |
5.52 | 20485159 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.03 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
2.88 | 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.50 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.62 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.62 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.27 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.66 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.34 | 10048152 11294989 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.47 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.36 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
8.58 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.58 | 16120746 15340226 12621046 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.11 | 16959395 15340226 8697196 18606429 16354765 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Carbamazepine |
4.75 | 10459572 |
MESH:D006965 |
Hyperplasia |
|
Carbamazepine |
5.25 | 18773962 |
MESH:D006967 |
Hypersensitivity |
|
fexofenadine |
5.35 | 17910814 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.98 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.98 | 18670907 18850075 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.87 | 12200463 12878042 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.36 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.50 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.35 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.76 | 12371664 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
2.91 | 21047994 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
oltipraz |
2.92 | 16544323 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.92 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
2.18 | 19363144 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
7.48 | 15890375 9163691 2125692 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
7.48 | 15975961 19812893 19073162 8742319 19482888 21047994 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.48 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
9.92 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
9.92 | 18308698 6150874 17172636 2563599 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
9.92 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
2.30 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.30 | 19555203 11884234 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Rifampin |
6.18 | 11422169 |
MESH:D008180 |
Lupus Erythematosus, Systemic |
|
Carbamazepine |
6.18 | 16628512 |
MESH:D008180 |
Lupus Erythematosus, Systemic |
|
Rifampin |
6.18 | 11422169 |
MESH:D008607 |
Mental Retardation |
|
Carbamazepine |
3.73 | 9014606 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.85 | 16801185 |
MESH:D009101 |
Multiple Myeloma |
|
fluvastatin |
4.54 | 16996129 |
MESH:D009164 |
Mycobacterium Infections |
|
Rifampin |
5.61 | 18474467 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.04 | 12213967 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.53 | 17484760 |
MESH:D009224 |
Myotonia Congenita |
|
Carbamazepine |
5.52 | 20399394 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.50 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.31 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Carbamazepine |
10.05 | 16990009 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
10.05 | 14600291 |
MESH:D010018 |
Osteomalacia |
|
Carbamazepine |
12.27 | 17016548 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
12.27 | 17016548 |
MESH:D010146 |
Pain |
|
Carbamazepine |
4.06 | 15215642 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
2.50 | 16965848 |
MESH:D010267 |
Parapsoriasis |
|
Carbamazepine |
5.74 | 16538176 |
OMIM:167400 |
PAROXYSMAL EXTREME PAIN DISORDER |
|
Carbamazepine |
5.97 | 17679678 17145499 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.31 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.59 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
9.05 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
9.05 | 2563599 |
MESH:D011248 |
Pregnancy Complications |
|
Carbamazepine |
5.19 | 9014606 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Carbamazepine |
10.02 | 9014606 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
10.02 | 11118676 11222880 11896295 11399792 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.83 | 15572423 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
3.54 | 18247401 12479363 15754350 16289102 16644109 |
MESH:D011537 |
Pruritus |
|
fexofenadine |
5.66 | 17133778 |
MESH:D019310 |
Pseudolymphoma |
|
Carbamazepine |
12.79 | 9591791 12752131 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
12.79 | 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.24 | 16882103 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.87 | 18990726 |
MESH:D012640 |
Seizures |
|
Carbamazepine |
6.45 | 15946322 9844417 19414003 16876388 16180713 9046859 16938433 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
6.45 | 16876388 3137016 11442880 4039156 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.87 | 6407741 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.05 | 16192470 |
MESH:D012893 |
Sleep Disorders |
|
Carbamazepine |
5.17 | 19414003 |
MESH:D013262 |
Stevens-Johnson Syndrome |
|
Carbamazepine |
5.25 | 16415921 15057820 19915237 16538176 20485159 19694795 18855540 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.96 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
3.07 | 1399818 |
MESH:D014376 |
Tuberculosis |
|
Rifampin |
4.78 | 18397238 15236969 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.05 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.66 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.31 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.50 | 17120751 |